These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiplatelet therapy with aspirin: from clinical trials to practice. Goodnight SH Thromb Haemost; 1995 Jul; 74(1):401-5. PubMed ID: 8578495 [No Abstract] [Full Text] [Related]
5. NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs. Calderone V; Rapposelli S; Martelli A; Digiacomo M; Testai L; Torri S; Marchetti P; Breschi MC; Balsamo A Bioorg Med Chem; 2009 Aug; 17(15):5426-32. PubMed ID: 19595600 [TBL] [Abstract][Full Text] [Related]
6. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model. Vilahur G; Segalés E; Salas E; Badimon L Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Keeble JE; Moore PK Br J Pharmacol; 2002 Oct; 137(3):295-310. PubMed ID: 12237248 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Herman AG; Moncada S Eur Heart J; 2005 Oct; 26(19):1945-55. PubMed ID: 15911567 [TBL] [Abstract][Full Text] [Related]
10. The many antithrombotic actions of nitric oxide. Tziros C; Freedman JE Curr Drug Targets; 2006 Oct; 7(10):1243-51. PubMed ID: 17073585 [TBL] [Abstract][Full Text] [Related]
13. [Mechanism of nitric oxide production in vascular endothelium and the significance as therapeutic target--special reference to the relationship with superoxides]. Oike M Fukuoka Igaku Zasshi; 2000 Oct; 91(10):256-65. PubMed ID: 11215249 [No Abstract] [Full Text] [Related]
14. Therapeutic role of nitric oxide as emerging molecule. Kumar S; Singh RK; Bhardwaj TR Biomed Pharmacother; 2017 Jan; 85():182-201. PubMed ID: 27940398 [TBL] [Abstract][Full Text] [Related]
15. NO-donors, part 9 : diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates. Abuo-Rahma Gel D; Horstmann A; Radwan MF; El-Emam A; Glusa E; Lehmann J Eur J Med Chem; 2005 Mar; 40(3):281-7. PubMed ID: 15725497 [TBL] [Abstract][Full Text] [Related]
17. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512 [TBL] [Abstract][Full Text] [Related]
18. Prevention of transient endothelial dysfunction in acute exercise: a friendly fire? Suvorava T; Kojda G Thromb Haemost; 2007 Mar; 97(3):331-3. PubMed ID: 17334496 [No Abstract] [Full Text] [Related]
19. [Nitric oxide. The role of guanylate cyclase in its physiological effects]. Severina IS Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497 [TBL] [Abstract][Full Text] [Related]